Region — International. Neutral scientific reference — not offered for sale here.
Cart · 0
Set region
Explore  /  Octocrylene
Research reference — not for sale

Octocrylene

C
lead outcome
Overall as a sunscreen UV filter
grades vary by outcome ↓
Small molecule (non-peptide)
also called — octocrilene · 2-ethylhexyl 2-cyano-3,3-diphenylacrylate · Uvinul N 539 · INCI: Octocrylene
UV filter (organic)photostabiliserUVB protectionwater resistance

Status: reference entry — not for sale. Neutral scientific reference only. No application instructions are published here; concentration figures are regulatory ceilings, not usage advice.

In brief

Octocrylene is in most organic sunscreens not for its own UV protection but as infrastructure: it is the most effective photostabiliser of avobenzone, retaining around 92% of UVA protection factor, and doubling as a solubiliser (avobenzone dissolves in it at ~13%) and a moderate UVB filter. Without it, much of the organic broad-spectrum market would not work. It also carries the most contested safety file of the common filters. A 2021 study (Downs et al.) found that octocrylene degrades into benzophenone as products age, using the FDA accelerated-stability protocol on 17 commercial sunscreens, and was independently corroborated on skincare products (28 of 39 tested containing octocrylene); benzophenone is Proposition 65-listed and banned by the FDA as a flavouring after high-dose rodent feeding studies. The authors called for a ban. That conclusion was formally rebutted in the same journal by researchers at the University Hospital of Zurich as "not evidence based", and SCCS reviewed octocrylene's endocrine risk in 2021 and found up to 10% safe. Two things get lost in the argument: the benzophenone formed depends more on overall product composition than on octocrylene concentration, and the rodent carcinogenicity data concern oral exposure, not topical. Meanwhile the best-established human effect — contact and photocontact allergy, notably in frequent sunscreen users — gets comparatively little attention. Graded C: excellent at its job, with an unresolved degradation question and the clearest allergy profile of the common filters.

Legal standing, by region
European Union
Permitted cosmetic UV filter, up to 10%

Listed in Annex VI of the EU Cosmetics Regulation. SCCS reviewed the potential endocrine risk of octocrylene in 2021 and concluded concentrations up to 10% are safe, including with respect to contact-allergic properties.

United Kingdom
Permitted cosmetic UV filter

Retained EU cosmetics framework; equivalent to the EU position.

United States
OTC drug — permitted up to 10%, Category III

Permitted at up to 10%. Classified Category III ("insufficient data") in the FDA's 2019 proposed order, alongside avobenzone, oxybenzone, octinoxate, octisalate and homosalate.

International
Widely permitted

In broad international use as both filter and photostabiliser. Global regulatory agencies have concluded octocrylene is safe as a UV filter in the product categories where it is used.

Evidence, by outcome
How we grade →

An honest grade per outcome — drawn from the evidence, not any catalogue. Hype and undemonstrated marketing claims grade low.

OutcomeEvidence base · effectGrade
Overall as a sunscreen UV filter
Read the rows below for the split: the A is for the stabilising job, the D for the benzophenone-degradation finding, and the ungraded rows for the open questions. The C is the honest weighting of the whole, not any one row.
Octocrylene is excellent at its actual job — photostabilising avobenzone (grade A, next row) — and a competent UVB / short-UVA filter in its own right. But it carries the most contested safety file of the common filters: a replicated (and disputed) finding that it degrades to benzophenone as product ages, documented systemic absorption above the FDA testing threshold, and the clearest contact / photocontact-allergy profile of the group. The overall grade weighs those together — it is not a verdict on the stabilising role, which is genuinely first-rate. · A valuable, near-ubiquitous formulation workhorse whose overall standing is tempered by an unresolved degradation question and a real allergy signal.
C
Photostabilising other filters (its primary role)
Worth being clear about what this grade means: octocrylene earns an A for **protecting another filter**, not for protecting skin directly. Its own UV contribution is secondary. This is why it appears in nearly every organic broad-spectrum sunscreen — it is infrastructure, not the headline act.
Formulation studies identify octocrylene as the most effective stabiliser of avobenzone (butyl methoxydibenzoylmethane), retaining roughly 92% of UVA protection factor with octocrylene alone, and reaching 90-100% photostability in optimised systems even after irradiation at 25 MED. It is also an excellent solubiliser — avobenzone dissolves in it at around 13% at ambient temperature — which lets formulators cut total oil content and improve skin feel. · Prevents the rapid photodegradation that otherwise costs avobenzone its UVA protection within 30-60 minutes.
A
UVB and short-UVA (UVA-II) filtering
Solid but unremarkable as a filter in its own right — it is not chosen for this. No long-UVA coverage.
A cinnamate derivative absorbing across roughly 280-320 nm with peak absorption around 303 nm and some UVA-II coverage. Lipophilic, which also contributes to water resistance in formulation. · Moderate, reliable SPF contribution alongside its stabilising function.
B
Degradation to benzophenone during storage
This finding is **contested, and both sides deserve stating.** The authors called for a ban. A formal comment in the same journal from the University Hospital of Zurich argued the conclusions were "not evidence based" and risked "doing more harm than good" by discouraging sunscreen use; the Personal Care Products Council issued a similar rebuttal. And SCCS, reviewing octocrylene's endocrine risk in 2021, concluded concentrations up to 10% are safe. One practical detail from the stability work is more useful than the argument: the amount of benzophenone formed **depends less on octocrylene concentration and more on the overall composition of the product** — so this is a formulation variable, not a simple dose relationship.
Downs CA, DiNardo JC, Stien D, Rodrigues AMS, Lebaron P. Benzophenone accumulates over time from the degradation of octocrylene in commercial sunscreen products. Chem Res Toxicol. 2021;34(4):1046-1054 — nine EU and eight US commercial products (in triplicate), subjected to the FDA accelerated stability aging protocol for 6 weeks, equivalent to one year at room temperature. Benzophenone accumulated during ageing. Independently corroborated by Foubert K, Dendooven E, Theunis M, et al. Contact Dermatitis. 2021;85:69-77 — laboratory testing of 39 skincare products (28 of them containing octocrylene). · Benzophenone content increases as octocrylene-containing products age — meaning an old sunscreen differs chemically from a fresh one.
D
Benzophenone hazard classification
The exposure route is the crux and is routinely elided. The rodent carcinogenicity data concern **high-dose oral feeding**; the FDA ban is on benzophenone as a **flavouring**. Extrapolating from that to trace quantities in a topical product is a substantial leap, and it is the leap that the Zurich comment and industry rebuttals object to. This entry does not resolve the dispute — it flags that a hazard classification from one exposure route is being applied to another.
Benzophenone is listed by the California Environmental Protection Agency under Proposition 65 and is prohibited by the FDA as a flavouring substance — that oral ban followed findings of increased renal tumours and possibly leukaemia and sarcoma in mice and rats fed high concentrations. · Classified as a possible carcinogen in oral-exposure contexts.
Systemic absorption
Same qualification as for every filter in that study: **the threshold is a trigger for further testing, not a finding of harm**, and the protocol was maximal-use rather than typical. Human and animal absorption of UV filters is well documented; the dermatology literature reports little data supporting direct toxicity in humans beyond rare contact and photocontact allergy.
Octocrylene was among the filters in the FDA's maximal-use plasma study (JAMA 2020, sunscreen applied to 75% of the body four times daily for four days). Reported plasma concentrations reached 7.8 ng/mL — above the 0.5 ng/mL threshold at which FDA regulations trigger additional safety testing, with accumulation over the four days. · Measurably absorbed, at higher plasma levels than avobenzone in the same protocol.
Contact and photocontact allergy
This is the best-established human adverse effect for this filter — more firmly grounded than the benzophenone debate — and it gets far less attention. Notably, an association with prior ketoprofen exposure has been described in the allergy literature.
Octocrylene is one of the more frequently reported organic filters in contact and photocontact allergy, with dermatologists noting cases particularly among frequent sunscreen users. Contact dermatitis is one of the few established adverse effects of sunscreen in the dermatology literature. · A real, if uncommon, sensitisation risk.
Environmental / marine impact
Proportion matters here. The dermatology literature is explicit that **climate change is the largest driver of coral bleaching**, and the sunscreen link rests on laboratory-based work. Environmental concern about these filters is legitimate; presenting it as a primary cause of reef damage is not supported.
Octocrylene and benzophenone feature in the marine toxicology literature — recent work reports impacts on gamete quality and fertilisation in the Pacific oyster. Degradation products of organic filters have been detected in marine ecosystems, and bans on oxybenzone and octinoxate in some jurisdictions followed laboratory work linking organic filters to coral bleaching. · Documented laboratory effects on marine organisms.
Disclosure

Vallydia sells its own cosmetic serums, and some ingredients graded here belong to the same categories as those products. Grades are drawn from the published evidence by the method we publish, and applied to our own ingredients on the same terms — our copper-peptide serum is graded no more kindly than the peptides it competes with. We disclose the interest so you can weigh it.

Trade names shown here (for example Matrixyl, Argireline, Syn-Ake) are the property of their respective owners and are used only to identify the ingredient under discussion. Their appearance implies no affiliation with, or endorsement by, the proprietor.

Evidence changes

Get notified if this changes

We track new research and update these grades as the evidence moves. Leave your email and we'll tell you if the evidence for Octocrylene changes - nothing else.

One ingredient, one purpose. No marketing, no sharing. Unsubscribe anytime. See our privacy policy.

Identity

Octocrylene is an organic UV filter — chemically a cinnamate derivative, 2-ethylhexyl 2-cyano-3,3-diphenylacrylate — absorbing UVB and short-wave UVA with peak absorption around 303 nm. It is lipophilic, which contributes to water resistance in sunscreen formulation.

But its main reason for being in a bottle is not its own absorption. Octocrylene is primarily a photostabiliser, included to keep other filters — above all avobenzone — from degrading in sunlight. That makes it one of the least visible and most structurally important ingredients in organic sun care.

⚠️ Three similar names appear in this entry and are constantly confused: octocrylene (this filter), benzophenone (its degradation product, and a separate substance), and oxybenzone (benzophenone-3, a different UV filter entirely).

Why it is in almost everything

Avobenzone is the principal long-UVA filter available in the US, and it degrades rapidly under sunlight through keto-enol tautomerism. Octocrylene solves this better than the alternatives: it absorbs the UV energy that would otherwise drive that degradation, retaining around 92% of UVA protection factor on its own, and reaching 90-100% photostability in optimised systems.

It also happens to be an excellent solubiliser for avobenzone — around 13% solubility at ambient temperature — which lets formulators reduce total oil content and improve the feel of the product. And it contributes its own UVB absorption to the overall SPF.

Three useful properties in one ingredient explain its near-ubiquity. It is infrastructure.

The benzophenone question — both sides

This is the most contested file among the common filters, and an honest entry has to present the dispute rather than pick a headline.

The finding. Downs and colleagues (Chemical Research in Toxicology, 2021) tested nine EU and eight US commercial sunscreen products in triplicate, subjected them to the FDA accelerated stability aging protocol for six weeks — equivalent to about a year at room temperature — and found that benzophenone accumulates as the product ages. A separate Belgian group (Foubert et al., Contact Dermatitis) independently detected benzophenone across octocrylene-containing skincare products (28 of 39 tested contained the filter). The authors of the first study called for a regulatory ban.

Why that matters, in principle. Benzophenone is listed under California's Proposition 65 and is prohibited by the FDA as a flavouring substance, following studies in which high dietary concentrations increased renal tumours — and possibly leukaemia and sarcoma — in mice and rats.

The rebuttal. A formal Comment published in the same journal, from the University Hospital of Zurich, argued that Downs et al. "reached conclusions that are not evidence based and risk doing more harm than good" — the harm being discouragement of sunscreen use. The Personal Care Products Council issued a parallel rebuttal, and global regulators have continued to treat octocrylene as safe in its permitted uses. SCCS specifically reviewed octocrylene's endocrine risk in 2021 and concluded that up to 10% is safe, including with respect to contact allergy.

What is worth extracting regardless of who is right. Two things. First, the exposure route: the rodent carcinogenicity data are oral, at high dietary doses, and the FDA ban is on benzophenone as a food flavouring. Applying that classification to trace amounts in a topical product is an extrapolation, and it is precisely the extrapolation the rebuttals contest. Second, and more practically useful: the stability work found the amount of benzophenone formed depends less on octocrylene concentration and more on the overall composition of the product — meaning this is a formulation variable, not a straightforward dose relationship, and no percentage on a label predicts it.

Reading the evidence honestly

What is solid: octocrylene works as a photostabiliser, and that function is genuinely valuable — an unstabilised avobenzone product loses its UVA protection within the hour. Removing octocrylene from the market without an equivalent replacement would make many sunscreens worse, which is the substance of the "more harm than good" objection.

What is genuinely uncertain: whether benzophenone accumulation in aged product constitutes a real human risk. The measurement is replicated; the interpretation is disputed; the regulatory bodies that have looked at it have not restricted the filter.

What is under-discussed: contact and photocontact allergy. This is the best-established human adverse effect of octocrylene — reported particularly among frequent sunscreen users, with a described association with prior ketoprofen exposure — and it receives a fraction of the attention that the benzophenone debate does. If you react to a sunscreen, this is a more likely explanation than anything in the carcinogenicity discussion.

On the environmental question: octocrylene and benzophenone appear in marine toxicology work, including recent findings on oyster fertilisation, and organic filter degradation products have been detected in marine ecosystems. That is a real line of research. But the dermatology literature is explicit that climate change is the largest driver of coral bleaching, and the sunscreen link rests on laboratory studies. Concern is warranted; attribution of reef damage primarily to sunscreen is not supported.

Grade C reflects an ingredient that does its actual job (stabilisation) excellently, while carrying an unresolved degradation question, documented systemic absorption, and the clearest allergy profile of the common filters.

Chemical identifiers

Cross-reference identifiers for the authoritative external databases — not a recipe, and nothing about how to use it.

PubChem CID22571
InChIKeyFMJSMJQBSVNSBF-UHFFFAOYSA-N
SMILESCCCCC(CC)COC(=O)C(=C(C1=CC=CC=C1)C2=CC=CC=C2)C#N

via PubChem exact-name match (octocrylene / 2-ethylhexyl 2-cyano-3,3- diphenylacrylate, CID 22571; C24H27NO2); CAS 6197-30-4. Distinct from benzophenone (its degradation product) and from oxybenzone (benzophenone-3) — both discussed in this entry and both the likely confusion. · high confidence

Sources — 7 cited
01Downs CA, DiNardo JC, Stien D, Rodrigues AMS, Lebaron P. Benzophenone accumulates over time from the degradation of octocrylene in commercial sunscreen products. Chem Res Toxicol. 2021;34(4):1046-1054.
02Comment on "Benzophenone accumulates over time from the degradation of octocrylene in commercial sunscreen products". Chem Res Toxicol. 2021 (rebuttal from University Hospital of Zurich).
03Foubert K, Dendooven E, Theunis M, et al. The presence of benzophenone in sunscreens and cosmetics containing the organic UV filter octocrylene: a laboratory study. Contact Dermatitis. 2021;85(1):69-77.
04Scientific Committee on Consumer Safety (SCCS). Opinion on octocrylene, 2021 — endocrine risk assessment, safe up to 10%.
05Matta MK, et al. Effect of sunscreen application on plasma concentration of sunscreen active ingredients: a randomized clinical trial. JAMA. 2020.
06Breakell T, et al. Ultraviolet filters: dissecting current facts and myths. J Clin Med. 2024;13(10):2986.
07The quest for avobenzone stabilizers and sunscreen photostability. Cosmetics & Toiletries (92% UVAPF retention, 25 MED).
Updated 2026-07-25 (the benzophenone question remains contested — re-check whether SCCS or FDA revisit octocrylene, and whether any jurisdiction restricts it.)

Grades reflect the published evidence, not our interest. No dosing, reconstitution, or administration is published for research compounds — that restraint is deliberate.

Related compounds
AvobenzoneB
Small molecule (non-peptide)
Zinc OxideA
Small molecule (non-peptide)
Bemotrizinol (Tinosorb S)A
Small molecule (non-peptide)
Vallydia

A neutral reference and a lawful-lane shop. Information for those who seek it — never promotion.

RegionInternational
ExploreRegisterThe Register — full indexCategoriesTrust & COAHow we gradeOpen data
ShopCosmetic peptidesJournalQuizzes
TermsPrivacyCookiesReturnsShippingImprint

This site provides neutral scientific reference and sells only products lawful in your region. Nothing here is medical advice, a recommendation, or an offer to supply unapproved medicines. No dosing or administration is published for research compounds. Cosmetic peptides per Regulation (EC) 1223/2009. Unapproved injectable peptides are neither sold nor advertised in the EU (Directive 2001/83/EC, Title VIII). © 2026 Vallydia.